Juvenescence News and Activities
Presence
Headquarters: United Kingdom (UK)
Acquisition, funding and merger involving Juvenescence.
- Juvenescence has just announced a $76 Million fundraising (posted on May 22 2025).
Executives
View the org chart displaying its 19 main executives
Most searched biographies at Juvenescence
- Richard Marshall CBE, Chief Executive Officer
- Jim Mellon, Deputy Chairman of the Board
- Gregory Bailey, Executive Chairman of the Board
Popular executive movements at Juvenescence
- Eileen Jennings-Brown has joined the company as Chief Technology Officer (posted on February 17 2026).
Create your alert
to follow the executive moves at Juvenescence.
Pharmaceuticals
Juvenescence has 1,915 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).
Popular M&A news in Pharmaceuticals
- AbbVie has announced the acquisition of Apogee Therapeutics (posted on June 23 2026).
- The new name of Stealth BioTherapeutics is Mighty Therapeutics. (posted on June 19 2026).
- Transcend has announced the acquisition of Otsuka America Pharmaceutical (posted on June 18 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Juvenescence
- Press Releases
- LyGenesis Announces First Patient Dosed in its Phase 2a Clinical Trial
- Chrysea Acquires Rodon Biologics to Strengthen Capabilities in Synthet
- Chrysea and Chalmers University Partner for Development of Benzylisoqu
- LyGenesis Raises $19M in Series A-2 Funding Led by Prime Movers Lab
- Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement
- LyGenesis and Imagine Pharma Announce Joint Research Collaboration to
- Relation Therapeutics announces launch of flagship integrated wet–dry
- Morphoceuticals Raises $8 million to Advance Electroceutical Approach
- Press Releases
- View more press releases Close
Social media about Juvenescence
- Juvenescence on Wikipedia, Google News & Yahoo Finance
- Juvenescence on LinkedIn, X (Twitter) & YouTube
